The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer

Chest

Volumn 140, Issue 2, 2011, Pages 433-440

  Jonnalagadda, Sirisha ^a   Smith, Cardinale ^b   Mhango, Grace ^b   Wisnivesky, Juan P ^b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK;

EID: 80051543457     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2885     Document Type: Article

References (31)

1. Jemal A, Seigel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.
2. Wisnivesky JP, Henschke CI, Swanson S, et al. Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg. 2010;251(3):550-554.
3. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111(6):1718-1723. (Pubitemid 27260108)
4. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010.
5. Martini N, Flehinger BJ, Nagasaki F, Hart B. Prognostic signifi cance of N1 disease in carcinoma of the lung. J Thorac Cardiovasc Surg. 1983;86(5):646-653. (Pubitemid 14228786)
6. Miyoshi K, Mimura T, Iwanaga K, Adachi S, Tsubota N, Okada M. Surgical treatment of clinical N1 non-small cell lung cancer: ongoing controversy over diagnosis and prognosis . Surg Today. 2010;40(5):428-432.
7. Marra A, Hillejan L, Zaboura G, Fujimoto T, Greschuchna D, Stamatis G. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. J Thorac Cardiovasc Surg. 2003;125(3):543-553. (Pubitemid 36373900)
8. Kang CH, Ra YJ, Kim YT, Jheon S-H, Sung SW, Kim JH. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer . Ann Thorac Surg. 2008;86(4):1092-1097.
9. Martini N, Burt ME, Bains MS, McCormack PM, Rusch VW, Ginsberg RJ. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg. 1992;54(3):460-466.
10. Sayar A, Turna A, Kiliçgün A, Solak O, Urer N, Gürses A. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung. Eur J Cardiothorac Surg. 2004;25(3):434-438. (Pubitemid 38340583)
11. Osaki T, Nagashima A, Yoshimatsu T, Tashima Y, Yasumoto K. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer. 2004;43(2):151-157. (Pubitemid 38114743)
12. Ueda K, Kaneda Y, Sakano H, et al. Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer. Jpn J Thorac Cardiovasc Surg. 2003;51(7):297-301. (Pubitemid 38166265)
13. SEER. Cancer statistics review 1975-2010. Bethesda, MD: National Cancer Institute; 2010. http://seer.cancer.gov/data/options.html. Updated 2010 with 2009 data. Accessed July 2010.
14. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg. 2008;206(2):239-246.
15. Bria E, Milella M, Sperduti I, et al. A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. Lung Cancer. 2009;66(3):365-371.
16. Sawyer TE, Bonner JA, Gould PM, et al. Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma. Ann Thorac Surg. 1999;68(4):1171-1176.
17. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 2003;21(6):1029-1034. (Pubitemid 46594131)
18. Varlotto JM, Recht A, Nikolov M, Flickinger JC, Decamp MM. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer. Cancer. 2009;115(4): 851- 858.
19. Ludwig MS, Goodman M, Miller DL, Johnstone PAS. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest. 2005;128(3):1545-1550. (Pubitemid 41324445)
20. Edwards BK, Johnson CH, Adamo M, Peace S, Fritz A, Percy-Laurry A. Histology coding and multiple primary rules. NAACR Narrative, Winter 2005 Edition. 2005:12.
21. Percy-Laurry AL, Johnson CH, Reichman ME, Adamo M, Lewis DR, Peace S. Revising the multiple primary and histology coding rule. J Registry Manag. 2007;34(3):81-86.
22. Nakagawa T, Okumura N, Kokado Y, Miyoshi K, Matsuoka T, Kameyama K. Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer. Interact Cardiovasc Thorac Surg. 2007;6(4):474-478. (Pubitemid 47403940)
23. The NCCN clinical practice guidelines in oncology: non-small cell lung cancer. Version V.I.2010. National Comprehensive Cancer Network Web site. http://nccn.org/professionals/physicians-glslf-guidelines.asp. Accessed August 2010.
24. Arriagada R, Dunant A, Pignon J-P, et al. Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer. J Clin Oncol. 2010;28(1):35-42.
25. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol. 2003;169(3):943-945. (Pubitemid 36188130)
26. Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23(34):8706-8712. (Pubitemid 46211514)
27. Lee H-Y, Choi H-J, Park K-J, et al. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma . Ann Surg Oncol. 2007;14(5):1712-1717. (Pubitemid 46791006)
28. Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol. 2003;10(9):1077-1085. (Pubitemid 40486832)
29. Scott WJ, Allen MS, Darling G, et al. Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. J Thorac Cardiovasc Surg. 2010;139(4):976-983.
30. Denlinger CE, Fernandez F, Meyers BF, et al. Lymph node evaluation in video-assisted thoracoscopic lobectomy versus lobectomy by thoracotomy. Ann Thorac Surg. 2010;89(6):1730-1736.
31. Percy C, Stanek E III, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health. 1981;71(3):242-250. (Pubitemid 11146407)